Rubiato, Gyne Kurl .
HRN: 21-07-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
CEFUROXIME 1.5GM (VIAL)
04/18/2026
04/19/2026
IV
1.5 Grams
Q8 X 3 Doses
SP NSD W RMLE, RBOW
Checking Initial Appropriateness
04/18/2026
CEFUROXIME 500MG (TAB)
04/19/2026
04/26/2026
PO
1 Tab
BID
SP NSD W RMLE; RBOW
Checking Initial Appropriateness